Publications by authors named "Brian D Quinlan"

Claim this Profile
E
Effect of mRNA-LNP components of two globally-marketed COVID-19 vaccines on efficacy and stability.
Lizhou Zhang, Kunal R More, Amrita Ojha, Cody B Jackson, Brian D Quinlan

NPJ Vaccines· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Reprogramming of the heavy-chain CDR3 regions of a human antibody repertoire.
Tianling Ou, Wenhui He, Brian D Quinlan, Yan Guo, Mai H Tran

Mol Ther· January 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
In vitro affinity maturation of broader and more-potent variants of the HIV-1-neutralizing antibody CAP256-VRC26.25.
Yiming Yin, Brian D Quinlan, Tianling Ou, Yan Guo, Wenhui He

Proc Natl Acad Sci U S A· July 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
An Engineered Receptor-Binding Domain Improves the Immunogenicity of Multivalent SARS-CoV-2 Vaccines.
Yan Guo, Wenhui He, Huihui Mou, Lizhou Zhang, Jing Chang, Brian D Quinlan

mBio· May 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mutations derived from horseshoe bat ACE2 orthologs enhance ACE2-Fc neutralization of SARS-CoV-2.
Huihui Mou, Brian D Quinlan, Haiyong Peng, Guanqun Liu, Yan Guo

PLoS Pathog· April 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A trimeric human angiotensin-converting enzyme 2 as an anti-SARS-CoV-2 agent.
Tianshu Xiao, Jianming Lu, Jun Zhang, Rebecca I Johnson, Lindsay G A McKay, Brian D Quinlan

Nat Struct Mol Biol· February 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
An engineered receptor-binding domain improves the immunogenicity of multivalent SARS-CoV-2 vaccines.
Brian D Quinlan, Wenhui He, Huihui Mou, Lizhou Zhang, Yan Guo

bioRxiv· November 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
SARS-CoV-2 spike-protein D614G mutation increases virion spike density and infectivity.
Lizhou Zhang, Cody B Jackson, Huihui Mou, Amrita Ojha, Haiyong Peng, Brian D Quinlan

Nat Commun· November 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A trimeric human angiotensin-converting enzyme 2 as an anti-SARS-CoV-2 agent in vitro.
Tianshu Xiao, Jianming Lu, Jun Zhang, Rebecca I Johnson, Lindsay G A McKay, Brian D Quinlan

bioRxiv· September 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mutations from bat ACE2 orthologs markedly enhance ACE2-Fc neutralization of SARS-CoV-2.
Huihui Mou, Brian D Quinlan, Haiyong Peng, Yan Guo, Shoujiao Peng

bioRxiv· June 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Diverse pathways of escape from all well-characterized VRC01-class broadly neutralizing HIV-1 antibodies.
Yuka Otsuka, Kimberly Schmitt, Brian D Quinlan, Matthew R Gardner, Barnett Alfant

PLoS Pathog· August 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
CD4-Induced Antibodies Promote Association of the HIV-1 Envelope Glycoprotein with CD4-Binding Site Antibodies.
Matthew R Gardner, Christoph H Fellinger, Neha R Prasad, Amber S Zhou, Hema R Kondur, Brian D Quinlan

J Virol· September 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
AAV-expressed eCD4-Ig provides durable protection from multiple SHIV challenges.
Matthew R Gardner, Lisa M Kattenhorn, Hema R Kondur, Markus von Schaewen, Tatyana Dorfman, Brian D Quinlan

Nature· March 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A double-mimetic peptide efficiently neutralizes HIV-1 by bridging the CD4- and coreceptor-binding sites of gp120.
Brian D Quinlan, Vinita R Joshi, Matthew R Gardner, Kourosh H Ebrahimi, Michael Farzan

J Virol· March 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Direct expression and validation of phage-selected peptide variants in mammalian cells.
Brian D Quinlan, Matthew R Gardner, Vinita R Joshi, Jessica J Chiang, Michael Farzan

J Biol Chem· June 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Enhanced recognition and neutralization of HIV-1 by antibody-derived CCR5-mimetic peptide variants.
Jessica J Chiang, Matthew R Gardner, Brian D Quinlan, Tatyana Dorfman, Hyeryun Choe

J Virol· November 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A tyrosine-sulfated CCR5-mimetic peptide promotes conformational transitions in the HIV-1 envelope glycoprotein.
Jo Ann Kwong, Tatyana Dorfman, Brian D Quinlan, Jessica J Chiang, Asim A Ahmed

J Virol· August 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
TRIM E3 ligases interfere with early and late stages of the retroviral life cycle.
Pradeep D Uchil, Brian D Quinlan, Wai-Tsing Chan, Joseph M Luna, Walther Mothes

PLoS Pathog· February 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis